Berberine, an isoquinoline alkaloid, modulates both STAT3 and AMPK pathways, showing efficacy in animal models and preliminary clinical studies
This label signifies that the products, such as BPC-157 and TB-500, are intended strictly for in-vitro laboratory research and development purposes
Scott Bradley Burris is the Medical Director at Hartwater Wellness, leading our clinical protocols for peptide therapy, as well as GLP-1 weight loss, IV therapy, hormone therapy, hyperbaric oxygen therapy, and other longevity care
Unfortunately, there is no way of knowing how a medicine will affect you until you begin to take it, but this is why GLP-1 receptor agonists are generally titrated up to the therapeutic dose over the course of several weeks, as it reduces the risk of experiencing severe or debilitating side effects